Those who hate maths should know this -- a mathematical model is here to improve the success rate of organ transplants.
The researchers are now working towards designing a tool capable of preventing rejection rate in organ transplants.
They created a mathematical algorithm that would indicate for each person - using their genetics, size, age, current medication and time since the transplant - what should be their immuno-suppressive drug dosage.
The process works towards understanding type of proteins in charge of metabolising the drugs (enzymes) for each patient who underwent organ transplant, thus establishing the exact dose of the immuno-suppressive drugs.
"This method is not only capable of giving an effective certainty at the moment of establishing the treatment but also save time and decrease rejection - increasing the quality of life, allowing the survival of more patients and optimising the health system," said Gilberto Castañeda Hernández from the department of Pharmacology at the Centre of Research and Advanced Studies of the National Polytechnic Institute (Cinvestav) in Mexico.
Currently, the quantity of drug to be administered is determined by trial and error. However, this process takes long and gives rise to complications that are translated into an acute rejection, said the study.
This would open "a new window of opportunity for kids, making it possible to determine the immuno-suppressive treatment correctly. Since children have a special metabolism, applying the analysis tools would bring better results", said the study that appeared in Science Daily.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
